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Abstract
I In nt tr ro od du uc ct ti io on n: :   Recurrent pregnancy loss (RPL) is a critical medical problem in
about 0.5-2% of women. The molecular genetic background for spontaneous
abortion is being increasingly understood, and some polymorphisms associated
with it have been reported. This study investigates alterations of the Bax gene
as a pro-apoptotic gene in women with idiopathic RPL. 
M Ma at te er ri ia al l   a an nd d   m me et th ho od ds s: :   The frequency of mutations in the Bax gene of 67
idiopathic RPL women was studied in comparison to a sample of 70 healthy
women. The promoter and the entire coding regions (exons 1-7) were amplified
using polymerase chain reaction (PCR). The purity of the PCR product was first
verified by electrophoresis on a 2% agarose gel. The amplified fragment was
then sequenced by automated DNA sequencing. 
R Re es su ul lt ts s: :   A statistically significant difference was observed between patients
and the control group regarding the frequency of alleles A(-179)G in the Bax
promoter region (p = 0.013). Also among patients, G90C and G95A transitions
were found in the coding region of exon 1 that change amino acid glutamine
(Q) to histidine (H) and arginine (R) to lysine (K), respectively. A statistically
significant association was observed between H allele (p = 0.0001) and K allele
(p < 0.0001) and the occurrence of RPL.
C Co on nc cl lu us si io on ns s: :   Our results indicate an association between A(-179)G mutation in
the Bax promoter and RPL. Moreover, two polymorphisms, G90C and G95A in
exon 1, found among our patients, could be considered as genetic factors making
people susceptible to miscarriages. According to our findings, the Bax gene has
an important role in pregnancy loss and the variations of this gene could help
in the assessment of RPL. 
K Ke ey y   w wo or rd ds s: :   BAX, repeated pregnancy loss, polymorphism, apoptosis.
Introduction
Pregnancy loss is the most common complication in pregnancies and
is  defined  as  the  unexpected  and  unplanned  spontaneous  loss  of
a pregnancy before the fetus is competent for extrauterine survival.
Clinically recognized pregnancies terminate as a miscarriage in about 
15% of cases [1]. Traditionally, recurrent abortion has been defined as the
occurrence of three or more clinically recognized pregnancy losses before
C Co or rr re es sp po on nd di in ng g   a au ut th ho or r: :
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20 weeks from the last menstrual period. About 
1 in 300 couples and 0.5-2% of women are affected
by repeated pregnancy loss (RPL) [2]. Assumed
aetiological factors are chromosomal aberrations,
uterine abnormalities, infectious disorders and
endocrine dysfunctions such as hypothyroidism 
and luteal phase deficiency. These factors are
present in about 50% of all women with RPL, but
in the majority of cases the cause is unknown 
or idiopathic [3, 4]. For idiopathic RPL, recent stu  -
dies propose that polymorphisms are susceptibi  -
lity factors, which increase the chance of miscar  -
riage [5-13].
In fact, biological processes supporting normal
pregnancy are mediated by a series of differential
gene expressions that can be affected by genomic
variations. The pattern of fragmentation is one of
these  processes,  and  is  a major  predictor  for
developmental potential [14]. While some patterns
of fragmentation have been ascribed to a process
of oncogenesis [15], a series of experiments also
suggested that a subset of embryo fragmentations
results  from  apoptotic-like  disintegration  [16].
Human  embryos  often  arrest  and  undergo
fragmentation at the 4-8 cell stage, when the
transition is supposed to happen from the maternal
to embryonic genome [17]. 
It is evident that embryo viability depends on
alterations in the expression of cell death regulatory
molecules, although there are still controversies
about apoptosis being a primary or secondary
process  in  cellular  fragmentation  [16].  This  is
supported by reports on alteration in the ratio of
Bcl-2 and Bax protein, as a very important apoptotic
related  protein,  in  bovine  viable  oocytes  and
embryos [18], as well as the elevated expression of
Bcl-2 and Bax during compaction of the human
embryo [19]. The modulated expression of Bax
mRNA in human viable and non-viable embryos is
another observation supporting this hypothesis [20].
The abnormal expression of apoptosis-related genes
is seen in RPL [21]. In the internal apoptotic or
mitochondrial pathway, one of the major genes of
the Bcl-2 family is the Bax gene, which has an
important role in fertilization and proliferation of
the cells. Bax is a death-promoting protein shown
to be a tumour suppressor and provoking cellular
apoptosis in vivo [22-24]. Also lower expression of
the Bax gene has been observed in some cases of
uncontrolled  cell  proliferation  such  as  breast
adenocarcinoma [25]. The Bax gene is located on
chromosome 19 and consists of seven exons and
a promoter region with four p53 binding sites [26].
Five isoforms of Bax have been documented. In this
study, we investigated Bax nucleotide alterations in
women with a history of RPL and compared these
data with the ones obtained from controls without
a history of miscarriage.
Material and methods
P Pa at ti ie en nt ts s   a an nd d   s sa am mp pl le es s
A total of 335 couples suffering from RPL were
referred to the Research and Clinical Center for
Infertility (Iran, Yazd) between September 2006
and June 2008. Among these people, 67 women
were screened as idiopathic at reproductive age.
Diag  nosis of RPL was based on a documented
history of at least three consecutive spontaneous
abortions before 20 weeks of gestation with the
same part  ner. In this study pregnancy loss was
confirmed mainly by observing the empty sac. 
The aborted material was also examined by the
pathologist from some other aspects. Neither these
examinations  nor  the  gynaecologist’s  referral
documents reported any case of hydatidiform
moles. RPL women under  went a standard dia  -
gnostic work-up to rule out any known cause of
RPL. The diagnostic pro  cedure included paternal
and  maternal  karyotype,  uterine  sonography,
TORCH infection study (Toxo  plasmosis, Rubella,
Cytomegalovirus, Herpes Simplex Virus type II and
Listeria), assessment of hormonal status, and
IgM/IgG anticardiolipin, antiphospholipid tests. All
of the cases were suffering from primary RPL and
had no history of child delivery. The control group
consisted of 70 women with at least two live births
and no history of pregnancy loss. All the controls
were at reproductive age and underwent sampling
in the labour room during their second or later
normal  delivery.  All  of  the  participants  were
informed about research and signed the consent
form approved by the ethical committee.
D DN NA A   e ex xt tr ra ac ct ti io on n   
Blood was collected from the women with RPL
and the control individuals in tubes containing 
potassium-EDTA. Genomic DNA was isolated from
the blood samples using a Flexigene blood DNA kit
(QIAGEN, Germany) according to the manufac  -
turer’s protocol. The isolated DNA was stored at
4°C until use.
P PC CR R/ /S Se eq qu ue en nc ci in ng g   a an na al ly ys si is s
Four pairs of primers were designed using 
the 5’ and 3’ flanking sequences to amplify the
promo  ter region and the exons of the Bax gene
(Table I).
The PCR reactions were performed in four series
according to the conditions detailed in Table II. The
reaction mixture for PCR contained 10 pM of each
primer, 1 unit of Taq polymerase (Cinnagene, Iran),
each dNTP at a final concentration of 200 µM, and
2.5 µl PCR buffer at a final volume of 25 µl. 1.5 µl of
DMSO was also used in the reaction mixture for the
promoter and exon 1 fragment.Arch Med Sci 1, February / 2011 119
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The PCR reactions were performed in a thermal
cycler (TECHNE) and the amplified fragments were
detected on 2% agarose gels (Figure 1).
The PCR-amplified fragments were purified and
then sequenced by a 3730XL ABI DNA analyzer
(Macrogen, Korea). DNA sequences were deter  -
mined using the same PCR primers. The results of
DNA sequence analysis were compared with the
published sequences in the NCBI database using
the Chromas and Clustal-X programs. Sequence
variants not found in the NCBI database were
identified as novel alterations.
S St ta at ti is st ti ic ca al l   a an na al ly ys si is s
All statistical analyses were carried out with
SPSS software package 16.0 (SPSS Inc., USA). Using
Chi-square and Fisher’s exact tests, the prevalence
of sequence variation was compared between case
and control groups. The odds ratio (OR) was used
as a measure of the strength of the association
between allele frequencies and idiopathic recurrent
miscarriage. P < 0.05 was considered statistically
significant.
Results
Our data show that the mean ± SD age of the
women with RPL at the time of blood sampling was
27.54 ±5.08 and the mean ± SD number of pregnancy
losses in this group was 3.84 ±1.62 (Table III). There
was a consanguineous marriage in 27 (40.3%)
women with RPL and 23 (32.9%) healthy women.
The difference between the two groups was not
significant (P = 0.366).
Sequencing  of  the  Bax  gene  showed  three
alterations in the promoter region and exon 1. 
The promoter genotype of 67 RPL and 70 healthy
women was determined from 400 nucleotides
before exon 1. An A(-179)G transition was observed
N Na am me e   o of f   p pr ri im me er rs s    S Se eq qu ue en nc ce e T Tm m P Pr ro od du uc ct t      s si iz ze e   [ [b bp p] ]
BAX-PE1-F 5'-CGG GGT TAT CTC TTG GGC-3' 58.2 663
BAX-PE1-R 5'-TGC TTG GAG ATC GCA CAG-3' 56.0
BAX-E2,3,4-F 5'-TCT TCC CTT CCT TTC TCC-3' 53.7 811
BAX-E2,3,4-R 5'-ACC TTG AGC ACC AGT TTG-3' 53.7
BAX-E5,6-F 5'-GAT TCT TGC TCT ATT GTC C-3' 52.4 710
BAX-E5,6-R 5'-TGA GGA GTC TCA CCC AAC-3' 56.0
BAX-E7-F 5'-ACT GAT GTC CCT GTC TCC-3' 56.0 303
BAX-E7-R 5'-GAC TCA GAT GCC GAA GTG-3' 56.0
T Ta ab bl le e   I I. .   Oligonucleotide primers used in the mutational screening of BAX gene
R RP PL L   w wo om me en n    H He ea al lt th hy y   w wo om me en n
Mean age ± SD  27.54 ±5.08 30.20 ±4.11
at miscarriage study [years]
Age at miscarriage  27 (19-40) 30 (22-39)
study [years]*
No. of live birth* 0 2 (2-4)
No. of miscarriage* 3 (3-11) 0
Mean ± SD of miscarriage 3.84 ±1.62 0
T Ta ab bl le e   I II II I. . Characteristics of RPL and healthy women
*Median (range)
F Fr ra ag gm me en nt ts s I In ni it ti ia al l    N Nu um mb be er r    D De en na at tu ur ra at ti io on n A An nn ne ea al li in ng g E Ex xt te en nt ti io on n F Fi in na al l   
d de en na at tu ur ra at ti io on n o of f   c cy yc cl le es s e ex xt te en nt ti io on n
Promoter and Exone 1 95°C – 5 min 35 95°C – 1 min 55°C – 1 min 72°C – 60 sec 72°C – 5 min
Exone 2, 3, 4 95°C – 5 min 35 94°C – 1 min 54°C – 1 min 72°C – 50 sec 72°C – 5 min
Exone 5, 6 95°C – 1 min 35 94°C – 1 min 58°C – 1 min 72°C – 50 sec 72°C – 5 min
Exone 7 95°C – 5 min 35 94°C – 1 min 56°C – 1 min 72°C –  30 sec 72°C – 5 min
T Ta ab bl le e   I II I. .   PCR programs for amplification of promoter and exons regions of BAX gene
12 M 3 4 5 6
663 bp
100 bp ladder
F Fi ig gu ur re e   1 1. . Demonstration of amplified 663-base-pair
promoter and exon 1. Lanes 1-6 show the amplified
fragment from samples and controls, and M shows
the 100-base-pair DNA ladder120 Arch Med Sci 1, February / 2011
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in the promoter region. The frequencies of the 
GG and AG genotypes were 95.52% and 4.48% 
among the RPL group and 81.43% and 18.57%
among the controls, respectively. This difference
was significant (P = 0.01). Also, the allele fre  quen  -
cies among the women with RPL and the controls
were 2.24% and 9.29% for allele A (wild type), and
97.76% and 90.71% for allele G (mutant type),
respectively. Therefore, an association could be
suggested between allele G and the occurrence of
RPL. (P = 0.012, odds ratio = 0.22; 0.05 < OR < 0.87;
Table V).
The substitution of guanine with cytosine (G > C)
at nucleotide 90 in the coding region of exon 1
changes the amino acid glutamine to histidine at
codon 7 (Q7H). This allele alteration was seen in 
33 (24.62%) of the RPL and 11 (7.86%) of the healthy
women (P = 0.0001, odds ratio = 3.83, 1.76 < OR 
< 8.51). Also, transition of guanine to adenine 
(G > A) was seen at nucleotide 95. In this alteration,
the amino acid arginine is changed to lysine at
location 9 (R9K) in 93 (69.40%) of the RPL and 20
(14.29%) of the healthy women (P < 0.0000, odds
ratio = 13.61, 7.19 < OR < 26). The genotype and the
allele frequency of these genotypes are shown in
Tables IV and V.
For exons 2, 3, 4, 5, 6, and 7, however, no nucleo  -
tide alterations were seen in the women with RPL.
Discussion
In this study, Bax gene nucleotide alterations were
investigated in RPL women. Also, the association
between the polymorphic sites in the promoter as
well as the coding regions of the Bax gene and the
occurrence of RPL was studied. One polymorphism
GG genotype
GGA CGGN CGGCTG
GA genotype
GGA CGG G CGGC T G
F Fi ig gu ur re e   2 2. .   Diagrams of BAX promoter variations in women
P Po ol ly ym mo or rp ph hi is sm ms s A Al ll le el le e   f fr re eq qu ue en nc cy y
W Wo om me en n   w wi it th h   R RP PL L H He ea al lt th hy y   w wo om me en n P P- -v va al lu ue eb b O Od dd ds s   r ra at ti io o
( (1 13 34 4   a al ll le el le es s) )a a ( (1 14 40 0   a al ll le el le es s) )a a 9 95 5% %   C CI I
A(-179)G Allele A 3 (2.24) 13 (9.29) 0.0128 0.22
Allele G 131 (97.76) 127 (90.71)
G90C Allele C 33 (24.62) 11 (7.86) 0.0001 3.83
Allele G 101 (75.37) 129 (92.14)
G95A Allele A 93 (69.40) 20 (14.29) < 0.0001 13.61
Allele G 41 (30.60) 120 (85.71)
T Ta ab bl le e   V V. .   Allele frequencies of Bax variations among RPL and healthy women
RPL – Repeated pregnancy loss, aValues in parenthesis are percentages, bPearson chi square test, CI – confidence interval
P Po ol ly ym mo or rp ph hi is sm ms s G Ge en no ot ty yp pe e   f fr re eq qu ue en nc cy y
W Wo om me en n   w wi it th h   R RP PL L   ( (n n = =   6 67 7) )a a H He ea al lt th hy y   w wo om me en n   ( (n n = =   7 70 0) )a a P P- -v va al lu ue eb b
A(-179)G Genotypes GG 64 (95.5) 57 (81.4) 0.010
GA 3 (4.5) 13 (18.6)
G90C Genotypes CC 11 (16.4) 4 (5.7) 0.005
CG 11 (16.4) 3 (4.3)
GG 45 (67.2) 63 (90)
G95A Genotypes AA 39 (58.2) 6 (8.6) < 0.001
AG 15 (22.4) 8 (11.4)
GG 13 (19.4) 56 (80)
T Ta ab bl le e   I IV V. . Genotypes of Bax variations among RPL and healthy women
RPL – Repeated pregnancy loss, aValues in parenthesis are percentages, bPearson chi square testArch Med Sci 1, February / 2011 121
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in the promoter region, A(-179)G, and two mutations
in exon 1, G90C and G95A, were identified as novel
variations in the Bax gene (Table IV).
There was a significant A(-179)G polymorphism
in the promoter region of the patients, which
suggests its involvement in spontaneous miscar  -
riages. The G(-248)A promoter polymorphism, which
is associated with increased lifespan of neutrophils
in osteomyelitis, has been previously reported [27].
Also, this variation results in a significantly lower
survival rate in patients with chronic lymphocytic
leukaemia [28]. Sequence variations in the Bax gene
promoter can affect its expression and its pro-
apoptotic function [24, 29]. It is known that changes
in the 5’ untranslated region sequence can inhibit
the  initiation  of  translation.  It  can  alter  the
expression of the Bax protein and most likely
implicates a post-transcriptional mechanism [30].
Thus, the polymorphism in its promoter region can
cause declined expression, activation and ultimately
apoptosis. However, according to our data the
frequency  of  promoter  polymorphism  in  RPL
women is lower than in control women, which
supports  this  hypothesis.  On  the  other  hand,
quantitative PCR and Western blot are suggested
for  future  studies  to  investigate  whether  the
observed mutation in the promoter region really
affects the expression of Bax protein in the tissues.
The changes found in exon 1 lead to amino acid
alterations and finally changed properties of Bax
protein. Based on the bioinformatic analysis, the
Q7H and R9K alterations lead to increased final total
energy  and  decreased  Bax  protein  stability
(http://swiss-model.expasy.org). These polymor  -
phisms can raise the pro-apoptotic activity of the
Bax  protein  in  relation  to  other  proteins  or
independently. Therefore, an increased tendency of
the cell to death or apoptosis will result. This
mechanism  could  underlie  the  role  of  these
variations in inducing pregnancy loss. However, to
support this hypothesis, site-directed mutagenesis
and in vitro expression studies are needed to provide
more functional data on the role of these mutations. 
Apoptosis,  or  programmed  cell  death,  is
responsible for a number of normal developmental
processes [31]. Since the regulation of cell death
and proliferation is required for successful human
pregnancy, apoptosis and its precise regulation are
crucial in a normal pregnancy [32, 33]. Therefore,
the aberrant expression of apoptosis-related genes
during development is also detrimental and can
lead to RPL. Interestingly, higher expression levels
of apoptosis-related genes, including the Bax gene,
were observed in chorionic villi of RPL patients
compared  to  normal  people  [34].  Bax  induces
apoptosis,  and  the  ratio  of  its  homo-  and
heterodimers to Bcl2 determines the fate of the cell
[35]. Different constitutive expressions of Bax are
related to the Bcl2/Bax ratio, leading to the failure
of  mitochondrial  disruption  associated  with
conformational  changes.  Dysfunction  and
dysregulation  of  the  apoptotic  programme  is
involved in some pathological conditions such 
as  cancers,  neurodegenerative  disorders  and
autoimmune diseases [36]. Also, apoptosis of villous
trophoblasts is upregulated in common pregnancy
diseases related to the placenta, intrauterine growth
retardation (IUGR), and pre-eclampsia [37, 38]. 
The Bax gene is also a primary transcriptional
target  after  p53  activation  [26,  39,  40].  It  is
possible that the other role of A(-179)G or G90C
and  G95A  polymorphisms  is  blunting  of  the
cellular  response  to  p53  activation  via  both
transcription-dependent and independent factors.
More research is needed to clarify how this pro-
apoptotic effect of Bax polymorphisms may cause
susceptibility to RPL. 
Because of the difficulties in obtaining aborted
materials, in the current study we focused solely on
the parents. 
Based on the studies conducted so far, more
than 40 gene products are differentially expressed
in the RPL compared to the normal women. These
genes may have regulatory roles in establishing or
maintaining normal pregnancy [21]. Therefore, any
nucleotide alterations in such genes may lead to
different expression and activity which endangers
the general health during pregnancy. A better
understanding of the genetic background and the
physiological significance of these polymorphisms
may help to manage subsequent pregnancies and
prevent pregnancy complications.
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